Background: While cystic fibrosis (CF) is the most common cause of bronchiectasis in childhood, non-CF bronchiectasis is associated with a wide variety of disorders. The objective of this study was to determine the relative prevalence and specific etiologies on non-CF bronchiectasis in childhood.
Background
Bronchiectasis in children without cystic fibrosis (non-CF bronchiectasis) is believed to be the end result of chronic or repeated episodes of environmental insults superimposed on a background of ? genetic vulnerability? ; these events lead to bronchial injury and dilatation [1] . In 1963, Clark described 116 cases of bronchiectasis in children aged 0 to 11 years [2] . See of those cases with an apparent etiology, most followed episodes of measles or pertussis. Radiographic evaluation of these children yielded a mixed picture: 1 child had collapse of an entire lung; 12 children had pulmonary cavitation with or without accompanying atelectasis and; 34 children had lobar atelectasis. Bronchography demonstrated bronchiectasis in all subjects tested.
The underlying ? vulnerabilities? in children are poorly defined. McDonnell, et al. generated a list of disorders that included immunodeficiency, connective tissue disorders, allergic bronchopulmonary aspergillosis as well as miscellaneous conditions including amyloidosis and endometriosis [3] . In another review, autoimmune disorders, primary ciliary dyskinesia, hypersensitivity syndromes, connective tissue disorders, and malignancy were listed among the potential causes of non-CF bronchiectasis [4] . In both cases, the etiologies listed were not specific for children and were not empirically derived. The goals of this systematic review were to determine the specific etiologies and relative prevalence of these disorders among children with non-CF bronchiectasis from studies reported in the literature.
Methods

Protocol
This study followed the Preferred Reporting Items in Systematic Reviews and Meta-Analyses (PRISMA) guidelines [5] .
Eligibility
The study protocol was developed by the authors a priori. The inclusion criteria for this review were: (1) any clinical trial, observational study or cross-sectional case series of 10 or more patients that included a delineation of the etiologies and/or the associated conditions with bronchiectasis; (2) subjects aged 21 years or younger; (3) cystic fibrosis was excluded as a diagnosis and; (4) the diagnosis of bronchiectasis was confirmed by computed tomography of the chest. Studies of adults and children were acceptable if the pediatric data was reported separately. Case reports, editorials and review articles were excluded.
Information sources
EMBASE, Medline, OVID Cochrane Reviews, Directory of Open Access Journals, Open Science Directory, EPSCO information services, and OAlster were searched from 1966 to March 25, 2014. The bibliographies of all of the selected studies were also reviewed.
Search
The main search term was ? non-CF bronchiectasis? . The following filters were used: human, all children and young adult. The searches were performed independently by two of the authors and the results were compared.
Study selection
Initial evaluation of each article was performed by one author (KSB) and then reviewed by another (MTD). In cases where study populations appeared to overlap, the study with the largest number of subjects was selected. Differences in judgment were resolved first by consensus; ties were adjudicated by the third author (SCA). All studies selected for inclusion were reviewed by the third author.
Data collection
For each selected study, the following information was recorded: inclusion criteria, number of patients, age range, diagnostic criteria, patient source and country of origin. Categorical and specific etiologies of bronchiectasis were also recorded for each study. Major categories of disease included primary immunodeficiencies, ciliary dyskinesia, infection, aspiration, idiopathic or unknown, congenital malformation, secondary immunodeficiencies, asthma, skeletal disorders, bronchiolitis obliterans, and others.
Within each category, specific etiologies were catalogued from those studies that provided specific data.
Synthesis of results
The categorical and specific etiologies of non-CF bronchiectasis were pooled to provide estimates of the relative prevalence for each disorder. Total sample size estimates for categorical comparisons were calculated from the total number of etiologies identified for the entire review. Total sample size estimates for the comparison of specific etiologies within individual categories were calculated from the total number of etiologies reported in a given category.
Sources of bias across studies
Patient sampling by number, locale and institution raised the concern of population homogeneity and possible over-or under-representation of a specific area or ethnic group. Variability in diagnostic evaluation and the identification of multiple etiologies for individual patients were also potential sources of bias in defining etiology. Inconsistencies and vagaries in nomenclature were a potential source of error when studies were combined.
Results and discussion
Study selection
The results of the literature search are shown in Figure 1 . Searches of the Medline and EMBASE databases yielded 202 references. An additional 289 citations were found by extensively searching the bibliographies of selected articles (Additional file 1). No additional studies were found by searching the OVID Cochrane Reviews, Directory of Open Access Journals, Open Science Directory, EPSCO information services, or OAlster. From the 491 studies identified, 448 studies were excluded after a cursory review of the title, abstract, and, when necessary, the results section. The full text of the remaining 43 articles was reviewed in detail. Thirty-one of the remaining studies were excluded: 22 reports had overlapping populations with other studies; 3 did not use computed tomography for the diagnosis of bronchiectasis; 1 did not have the minimum number of patients; 2 studies included the same subjects as previous publications; 2 included adult populations that could not be separated from the pediatric subjects and; 1 did not contain any etiology data.
Study characteristics and outcomes
The characteristics of the 12 studies that met the inclusion criteria and comprise the basis of this review are shown in Table 1 [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . The reports ranged in size from 22 to 151 participants per study. Non-CF bronchiectasis was defined by computed tomography [18] ; in one study, 96% of patients underwent computed tomography [6] . Together, these reports represent a worldwide sample (Australia, Ireland, Turkey, Saudi Arabia, United Kingdom, New Zealand, Alaska, Italy, and Korea). Children were drawn from single centers in 8 studies [6] [7] [8] [9] [10] [11] [12] 16] , multiple centers in 3 studies [13] [14] [15] and an entire region in 1 study [17] ; the total number of patients included in this review is 989.
The underlying conditions associated with non-CF bronchiectasis in children, by study, are shown in Table 2 . Banjar, et al. and Eastham et al. reported multiple associations in individual patients [6, 7] . Attempts to contact the authors were unsuccessful. With the inclusion of these studies, the total number of associations (994) exceeds the total number of patients reported (989). In two studies, the most likely association of multiple associations reported for individual patients was the only one counted (e.g. primary immunodeficiency is a more likely association than infection since it was the likely predisposition for the infection) [7, 8] . Singleton et al. described patients with definite and probable bronchiectasis [16] ; only definite cases were included.
Synthesis of results
The categorical disease processes associated with childhood non-CF bronchiectasis are shown in Table 3 . Nine hundred and ninety nine associations were identified in 989 patients. No association was found in 366 subjects (40%). Of the identified associations, the most common were infection (173 subjects, 19%), primary immunodeficiency (160 subjects, 18%), aspiration/foreign body (95 subjects, 10%) and ciliary dyskinesia, including Kartagener? s Syndrome (91 subjects, 10%).
The infections associated with non-CF bronchiectasis are shown in Table 4 . Of the 173 patients with an infectious process, 108 (62%) were identified by a specific disease entity. Pneumonia was the most common association (61%) followed by measles (14%), tuberculosis (11%) and pertussis (5%). Varicella, neonatal pneumonia, allergic bronchopulmonary aspergillosis and adenoviral pneumonia were rarely associated with bronchiectasis.
Of the 160 children with bronchiectasis and primary immunodeficiency, 131 (83%) cases were identified by a specific entity (Table 5 ). B cell disorders accounted for 97 (73.5%) of the primary immunodeficiencies identified: IgG and IgG subclass deficiencies were the most common (66.5%) and IgA deficiency accounted for 6%. A heterogeneous group of combined immunodeficiency disorders accounted for 10% of cases while 7.5% of primary immunodeficiencies resulted from T cell disorders. Of the 29 subjects with secondary immunodeficiencies, 18 (62%) were children who had received chemotherapy for an underlying oncologic process; 6 (20%) of children had HIV/AIDS and 5 (18%) were cardiac transplant recipients.
Of the 95 children with bronchiectasis and aspiration, 18 instances (20%) resulted from aspiration of a foreign body; 14 children (15%) had seizures and recurrent aspiration. Thirty-four children had an underlying congenital malformation and 27 (79%) had a specific entity identified (Table 6 ). Tracheoesophageal fistulae and cystic lung disease accounted for 52% and 19% of cases, respectively.
Risk of bias
The studies included in this review ranged in size from 22 to 151 subjects; the largest study accounted for 17% of the total sample. The countries of origin contributed samples from 9 different countries and multiple continents. Only 1 study drew patients from a large, regional database; the remaining studies represented one or two clinical sites. All of the studies were retrospective in nature and none employed a standardized diagnostic evaluation. Vagaries in nomenclature occurred among patients diagnosed with primary immunodeficiencies deficiencies. Patients with antibody deficiency, antibody dysfunction or IgG deficiency were grouped together as IgG deficiency; those with combined immunodeficiency were grouped together with severe combined immunodeficiency. Identifying patients with ? idiopathic? disease is also confusing since this implies a singular, as yet unidentified process. Three studies reported multiple underlying disorders for individual patients with non-CF bronchiectasis [6] [7] [8] . In two, patients with multiple ascribed etiologies could not be identified [6, 7] . Non-CF bronchiectasis in children usually has an indolent onset and presents with chronic respiratory symptoms [2] [3] [4] . Cough with daily sputum production is the most common clinical presentation and may be present for years before diagnosis. Hemoptysis, pleuritic chest pain, pulmonary osteoarthropathy, and delayed growth are additional findings associated with non-CF bronchiectasis. The definitive diagnosis of bronchiectasis requires chest imaging usually with high resolution computed tomography [18] .
While the pathophysiology of bronchiectasis is well defined, the etiologies of non-CF bronchiectasis are varied [1, 3] . The data presented in this review suggest that 60% of children with this disorder have an underlying IgA deficiency 9 7%
B cell deficiency NOS 1 1%
T cell disorders 9 7%
Hyper IgE syndrome 3 2%
Hyper IgM syndrome 2 2%
T Cell deficiency 3 2%
Chronic mucocutaneous candidiasis 1 1%
Combined immunodeficiency 13 10%
Severe combined immunodeficiency** 9 7%
Ataxia-telangiectasia 2 2%
Wiskott-Aldrich syndrome 2 2%
Chronic granulomatous disease 7 5%
Barre lymphocyte syndrome/MHC class II deficiency 2 2 % Mannose-binding protein deficiency 1 1%
Other disorders 2 2%
*Includes patients identified as common variable immunodeficiency (30), IgG deficiency (13), agammaglobulinemia (10) and antibody deficiency or dysfunction (10) . **Not otherwise specified. Selection bias is a major limitation of this review. Since all of the studies selected for review were retrospective in design, the possibility exists that patients may have been missed. The subjects included in this study represent 9 different countries, lending credence to the notion that the sample is unbiased. Conversely, U.S. children are underrepresented since the only American study was from Alaska. Finally, 8 of the studies selected for review reported patients from a single clinical site and 3 studies used 2 clinical sites; only 1 study employed a regional database [17] .
Misidentification and failure to identify an etiology also contribute to the limitation of this review. Identifying multiple etiologies in individual patients occurred in 2 studies, raising the concern of over representation of specific etiologies [6, 7] . The selected studies contained little to no detail regarding the diagnostic approach used to identify the etiology of non-CF bronchiectasis. The absence of a detailed, unified approach to the diagnostic evaluation of these children across studies may have overestimated the number of children without a diagnosis or may have misdiagnosed an unknown number of subjects. Variability in nomenclature compounds this problem. The most common etiology of non-CF bronchiectasis was severe pneumonia, but detail regarding the infectious agent was not available. The second most common etiology was a B cell disorder; unfortunately some subjects were identified with IgG deficiency or an antibody disorder leaving the true diagnosis open to speculation.
Conclusions
The majority of children with non-CF bronchiectasis have an underlying cause of the disorder. Severe pneumonia, B cell abnormalities, recurrent aspiration or aspiration of a foreign body and ciliary dyskinesia are the most common etiologies. A focused history and laboratory investigation is suggested in the evaluation of these children. A large prospective study with a predefined diagnostic evaluation is required to substantiate the conclusions of this review.
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